Tbx1: Transcriptional and Developmental Functions

Current Topics in Developmental Biology

Volumn 122, Issue , 2017, Pages 223-243

  Baldini, A ^a,b   Fulcoli, F G ^b   Illingworth, E ^c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

^c UNIVERSITY OF SALERNO   (Italy)

Author keywords

Cardiac development; DiGeorge syndrome; DNA binding; Histone modifications; Pharyngeal apparatus; Tbx1

Indexed keywords

T BOX TRANSCRIPTION FACTOR;

ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; EMBRYO DEVELOPMENT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; MUTATION;

ANIMALS; EMBRYONIC DEVELOPMENT; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MODELS, BIOLOGICAL; MUTATION; T-BOX DOMAIN PROTEINS; TRANSCRIPTION, GENETIC;

EID: 84994111939     PISSN: 00702153     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.ctdb.2016.08.002     Document Type: Chapter

References (90)

1. Arnold, J.S., Braunstein, E.M., Ohyama, T., Groves, A.K., Adams, J.C., Brown, M.C., et al. Tissue-specific roles of Tbx1 in the development of the outer, middle and inner ear, defective in 22q11DS patients. Human Molecular Genetics 15 (2006), 1629–1639.
2. Basson, M.A., van Ravenswaaij-Arts, C., Functional insights into chromatin remodelling from studies on CHARGE syndrome. Trends in Genetics 31 (2015), 600–611.
3. Braff, D.L., Geyer, M.A., Swerdlow, N.R., Human studies of prepulse inhibition of startle: Normal subjects, patient groups, and pharmacological studies. Psychopharmacology 156 (2001), 234–258.
4. Braunstein, E.M., Crenshaw Iii, E.B., Morrow, B.E., Adams, J.C., Cooperative function of Tbx1 and Brn4 in the periotic mesenchyme is necessary for cochlea formation. Journal of the Association for Research in Otolaryngology 9 (2008), 33–43.
5. Brown, C.B., Wenning, J.M., Lu, M.M., Epstein, D.J., Meyers, E.N., Epstein, J.A., Cre-mediated excision of Fgf8 in the Tbx1 expression domain reveals a critical role for Fgf8 in cardiovascular development in the mouse. Developmental Biology 267 (2004), 190–202.
6. Calmont, A., Ivins, S., Van Bueren, K.L., Papangeli, I., Kyriakopoulou, V., Andrews, W.D., et al. Tbx1 controls cardiac neural crest cell migration during arch artery development by regulating Gbx2 expression in the pharyngeal ectoderm. Development 136 (2009), 3173–3183.
7. Cao, H., Florez, S., Amen, M., Huynh, T., Skobe, Z., Baldini, A., et al. Tbx1 regulates progenitor cell proliferation in the dental epithelium by modulating PITX2 activation of p21. Developmental Biology 347 (2010), 289–300.
8. Caprio, C., Baldini, A., p53 suppression partially rescues the mutant phenotype in mouse models of DiGeorge syndrome. Proceedings of the National Academy of Sciences of the United States of America 111 (2014), 13385–13390.
9. Castellanos, R., Xie, Q., Zheng, D., Cvekl, A., Morrow, B.E., Mammalian TBX1 preferentially binds and regulates downstream targets via a tandem T-site repeat. PLoS One, 9(5), 2014, e95151.
10. Chen, L., Fulcoli, F.G., Ferrentino, R., Martucciello, S., Illingworth, E.A., Baldini, A., Transcriptional control in cardiac progenitors: Tbx1 interacts with the BAF chromatin remodeling complex and regulates Wnt5a. PLoS Genetics, 8(3), 2012, e1002571.
11. Chen, L., Fulcoli, F.G., Tang, S., Baldini, A., Tbx1 regulates proliferation and differentiation of multipotent heart progenitors. Circulation Research 105 (2009), 842–851.
12. Chen, L., Mupo, A., Huynh, T., Cioffi, S., Woods, M., Jin, C., et al. Tbx1 regulates Vegfr3 and is required for lymphatic vessel development. Journal of Cell Biology 189 (2010), 417–424.
13. Cioffi, S., Martucciello, S., Fulcoli, F.G., Bilio, M., Ferrentino, R., Nusco, E., et al. Tbx1 regulates brain vascularization. Human Molecular Genetics 23 (2014), 78–89.
14. Coll, M., Seidman, J.G., Müller, C.W., Structure of the DNA-bound T-box domain of human TBX3, a transcription factor responsible for ulnar-mammary syndrome. Structure 10 (2002), 343–356.
15. Creyghton, M.P., Cheng, A.W., Welstead, G.G., Kooistra, T., Carey, B.W., Steine, E.J., et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proceedings of the National Academy of Sciences of the United States of America 107 (2010), 21931–21936.
16. Dellinger, M.T., Brekken, R.A., Phosphorylation of Akt and ERK1/2 is required for VEGF-A/VEGFR2-induced proliferation and migration of lymphatic endothelium. PLoS One, 6(12), 2011, e28947.
17. Dellinger, M.T., Meadows, S.M., Wynne, K., Cleaver, O., Brekken, R.A., Vascular endothelial growth factor receptor-2 promotes the development of the lymphatic vasculature. PLoS One, 8(9), 2013, e74686.
18. Diogo, R., Kelly, R.G., Christiaen, L., Levine, M., Ziermann, J.M., Molnar, J.L., et al. A new heart for a new head in vertebrate cardiopharyngeal evolution. Nature 520 (2015), 466–473.
19. Dumont, D.J., Jussila, L., Taipale, J., Lymboussaki, A., Mustonen, T., Pajusola, K., et al. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 282 (1998), 946–949.
20. El Omari, K., De Mesmaeker, J., Karia, D., Ginn, H., Bhattacharya, S., Mancini, E.J., Structure of the DNA-bound T-box domain of human TBX1, a transcription factor associated with the DiGeorge syndrome. Proteins 80 (2012), 655–660.
21. Flore, G., Cioffi, S., Bilio, M., Illingworth, E., Cortical development requires mesodermal expression of Tbx1, a gene haploinsufficient in 22q11.2 deletion syndrome. Cerebral Cortex, 2016, 10.1093/cercor/bhw076 Epub ahead of print.
22. Francou, A., Saint-Michel, E., Mesbah, K., Kelly, R.G., TBX1 regulates epithelial polarity and dynamic basal filopodia in the second heart field. Development 141 (2014), 4320–4331.
23. Fulcoli, F.G., Franzese, M., Liu, X., Zhang, Z., Angelini, C., Baldini, A., Rebalancing gene haploinsufficiency in vivo by targeting chromatin. Nature Communications, 7, 2016, 11688.
24. Fulcoli, F.G., Huynh, T., Scambler, P.J., Baldini, A., Tbx1 regulates the BMP-Smad1 pathway in a transcription independent manner. PLoS One, 4, 2009, e6049.
25. Garg, V., Yamagishi, C., Hu, T., Kathiriya, I.S., Yamagishi, H., Srivastava, D., Tbx1, a DiGeorge syndrome candidate gene, is regulated by sonic hedgehog during pharyngeal arch development. Developmental Biology 235 (2001), 62–73.
26. Ghosh, T.K., Packham, E.A., Bonser, A.J., Robinson, T.E., Cross, S.J., Brook, J.D., Characterization of the TBX5 binding site and analysis of mutations that cause Holt-Oram syndrome. Human Molecular Genetics 10 (2001), 1983–1994.
27. Gopalakrishnan, S., Comai, G., Sambasivan, R., Francou, A., Kelly, R.G., Tajbakhsh, S., A cranial mesoderm origin for esophagus striated muscles. Developmental Cell 34:6 (2015), 694–704.
28. Grifone, R., Jarry, T., Dandonneau, M., Grenier, J., Duprez, D., Kelly, R.G., Properties of branchiomeric and somite-derived muscle development in Tbx1 mutant embryos. Developmental Dynamics 237 (2008), 3071–3078.
29. Guris, D.L., Duester, G., Papaioannou, V.E., Imamoto, A., Dose-dependent interaction of Tbx1 and Crkl and locally aberrant RA signaling in a model of del22q11 syndrome. Developmental Cell 10 (2006), 81–92.
30. Hiramoto, T., Kang, G., Suzuki, G., Satoh, Y., Kucherlapati, R., Watanabe, Y., et al. Tbx1: Identification of a 22q11.2 gene as a risk factor for autism spectrum disorder in a mouse model. Human Molecular Genetics 20 (2011), 4775–4785.
31. Huynh, T., Chen, L., Terrell, P., Baldini, A., A fate map of Tbx1 expressing cells reveals heterogeneity in the second cardiac field. Genesis 45 (2007), 470–475.
32. Ivins, S., Lammerts van Beuren, K., Roberts, C., James, C., Lindsay, E., Baldini, A., et al. Microarray analysis detects differentially expressed genes in the pharyngeal region of mice lacking Tbx1. Developmental Biology 285:2 (2005), 554–569.
33. Jerome, L.A., Papaioannou, V.E., DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1. Nature Genetics 27 (2001), 286–291.
34. Karkkainen, M.J., Ferrell, R.E., Lawrence, E.C., Kimak, M.A., Levinson, K.L., McTigue, M.A., et al. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nature Genetics 25:2 (2000), 153–159.
35. Karkkainen, M.J., Jussila, L., Ferrell, R.E., Finegold, D.N., Alitalo, K., Molecular regulation of lymphangiogenesis and targets for tissue oedema. Trends in Molecular Medicine 7:1 (2001), 18–22.
36. Kelly, R.G., The second heart field. Current Topics in Developmental Biology 100 (2012), 33–65.
37. Kelly, R.G., Jerome-Majewska, L.A., Papaioannou, V.E., The del22q11.2 candidate gene Tbx1 regulates branchiomeric myogenesis. Human Molecular Genetics 13 (2004), 2829–2840.
38. Kispert, A., Herrmann, B.G., The Brachyury gene encodes a novel DNA binding protein. EMBO Journal 12 (1993), 3211–3220.
39. Klotz, L., Norman, S., Vieira, J.M., Masters, M., Rohling, M., Dubé, K.N., et al. Cardiac lymphatics are heterogeneous in origin and respond to injury. Nature 522 (2015), 62–67.
40. Lania, G., Ferrentino, R., Baldini, A., TBX1 Represses Vegfr2 Gene Expression and Enhances the Cardiac Fate of VEGFR2 + Cells. PLoS One, 10, 2015, e0138525.
41. Lania, G., Zhang, Z., Huynh, T., Caprio, C., Moon, A.M., Vitelli, F., et al. Early thyroid development requires a Tbx1-Fgf8 pathway. Developmental Biology 328 (2009), 109–117.
42. Larsimont, J.-C., Youssef, K.K., Sánchez-Danés, A., Sukumaran, V., Defrance, M., Delatte, B., et al. Sox9 controls self-renewal of oncogene targeted cells and links tumor initiation and invasion. Cell Stem Cell 17 (2015), 60–73.
43. Liao, J., Aggarwal, V.S., Nowotschin, S., Bondarev, A., Lipner, S., Morrow, B.E., Identification of downstream genetic pathways of Tbx1 in the second heart field. Developmental Biology 316 (2008), 524–537.
44. Lindsay, E.A., Vitelli, F., Su, H., Morishima, M., Huynh, T., Pramparo, T., et al. Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice. Nature 410 (2001), 97–101.
45. Lingbeek, M.E., Jacobs, J.J., van Lohuizen, M., The T-box repressors TBX2 and TBX3 specifically regulate the tumor suppressor gene p14ARF via a variant T-site in the initiator. Journal of Biological Chemistry 277 (2002), 26120–26127.
46. Long, J.M., LaPorte, P., Merscher, S., Funke, B., Saint-Jore, B., Puech, A., et al. Behavior of mice with mutations in the conserved region deleted in velocardiofacial/DiGeorge syndrome. Neurogenetics 7 (2006), 247–257.
47. Luna-Zurita, L., Stirnimann, C.U., Glatt, S., Kaynak, B.L., Thomas, S., Baudin, F., et al. Complex interdependence regulates heterotypic transcription factor distribution and coordinates cardiogenesis. Cell 164 (2016), 999–1014.
48. Martinez-Corral, I., Ulvmar, M.H., Stanczuk, L., Tatin, F., Kizhatil, K., John, S.W.M., et al. Nonvenous origin of dermal lymphatic vasculature. Circulation Research 116 (2015), 1649–1654.
49. McAlonan, G.M., Daly, E., Kumari, V., Critchley, H.D., van Amelsvoort, T., Suckling, J., et al. Brain anatomy and sensorimotor gating in Asperger's syndrome. Brain: A Journal of Neurology 125 (2002), 1594–1606.
50. McCabe, K.L., Atkinson, R.J., Cooper, G., Melville, J.L., Harris, J., Schall, U., et al. Pre-pulse inhibition and antisaccade performance indicate impaired attention modulation of cognitive inhibition in 22q11.2 deletion syndrome (22q11DS). Journal of Neurodevelopmental Disorders, 6, 2014, 38.
51. Merscher, S., Funke, B., Epstein, J.A., Heyer, J., Puech, A., Min Lu, M.M., et al. TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell 104 (2001), 619–629.
52. Moon, A.M., Guris, D.L., Seo, J.H., Li, L., Hammond, J., Talbot, A., et al. Crkl deficiency disrupts fgf8 signaling in a mouse model of 22q11 deletion syndromes. Developmental Cell 10 (2006), 71–80.
53. Mori, A.D., Bruneau, B.G., TBX5 mutations and congenital heart disease: Holt-Oram syndrome revealed. Current Opinion in Cardiology 19 (2004), 211–215.
54. Mori, A.D., Zhu, Y., Vahora, I., Nieman, B., Koshiba-Takeuchi, K., Davidson, L., et al. Tbx5-dependent rheostatic control of cardiac gene expression and morphogenesis. Developmental Biology 297 (2006), 566–586.
55. Müller, C.W., Herrmann, B.G., Crystallographic structure of the T domain-DNA complex of the Brachyury transcription factor. Nature 389 (1997), 884–888.
56. Narlikar, L., MuMoD: A Bayesian approach to detect multiple modes of protein-DNA binding from genome-wide ChIP data. Nucleic Acids Research 41 (2013), 21–32.
57. Nowotschin, S., Liao, J., Gage, P.J., Epstein, J.A., Campione, M., Morrow, B.E., Tbx1 affects asymmetric cardiac morphogenesis by regulating Pitx2 in the secondary heart field. Development 133 (2006), 1565–1573.
58. Ogata, T., Niihori, T., Tanaka, N., Kawai, M., Nagashima, T., Funayama, R., et al. TBX1 mutation identified by exome sequencing in a Japanese family with 22q11.2 deletion syndrome-like craniofacial features and hypocalcemia. PLoS One, 9(3), 2014, e91598.
59. Pane, L.S., Zhang, Z., Ferrentino, R., Huynh, T., Cutillo, L., Baldini, A., Tbx1 is a negative modulator of Mef2c. Human Molecular Genetics 21 (2012), 2485–2496.
60. Papaioannou, V.E., The T-box gene family: Emerging roles in development, stem cells and cancer. Development 141 (2014), 3819–3833.
61. Papangeli, I., Scambler, P.J., Tbx1 genetically interacts with the transforming growth factor-β/bone morphogenetic protein inhibitor Smad7 during great vessel remodeling. Circulation Research 112 (2013), 90–102.
62. Paylor, R., Glaser, B., Mupo, A., Ataliotis, P., Spencer, C., Sobotka, A., et al. Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: Implications for 22q11 deletion syndrome. Proceedings of the National Academy of Sciences of the United States of America 103 (2006), 7729–7734.
63. Rana, M.S., Théveniau-Ruissy, M., De Bono, C., Mesbah, K., Francou, A., Rammah, M., et al. Tbx1 coordinates addition of posterior second heart field progenitor cells to the arterial and venous poles of the heart. Circulation Research 115 (2014), 790–799.
64. Randall, V., McCue, K., Roberts, C., Kyriakopoulou, V., Beddow, S., Barrett, A.N., et al. Great vessel development requires biallelic expression of Chd7 and Tbx1 in pharyngeal ectoderm in mice. Journal of Clinical Investigation 119 (2009), 3301–3310.
65. Roberts, C., Ivins, S., Cook, A.C., Baldini, A., Scambler, P.J., Cyp26 genes a1, b1 and c1 are down-regulated in Tbx1 null mice and inhibition of Cyp26 enzyme function produces a phenocopy of DiGeorge syndrome in the chick. Human Molecular Genetics 15 (2006), 3394–3410.
66. Saharinen, P., Eklund, L., Pulkki, K., Bono, P., Alitalo, K., VEGF and angiopoietin signaling in tumor angiogenesis and metastasis. Trends in Molecular Medicine 17 (2011), 347–362.
67. Saharinen, P., Helotera, H., Miettinen, J., Norrmen, C., D'Amico, G., Jeltsch, M., et al. Claudin-like protein 24 interacts with the VEGFR-2 and VEGFR-3 pathways and regulates lymphatic vessel development. Genes & Development 24 (2010), 875–880.
68. Sambasivan, R., Gayraud-Morel, B., Dumas, G., Cimper, C., Paisant, S., Kelly, R.G., et al. Distinct regulatory cascades govern extraocular and pharyngeal arch muscle progenitor cell fates. Developmental Cell 16 (2009), 810–821.
69. Schaub, C., März, J., Reim, I., Frasch, M., Org-1-dependent lineage reprogramming generates the ventral longitudinal musculature of the Drosophila heart. Current Biology 25 (2015), 488–494.
70. Schaub, C., Nagaso, H., Jin, H., Frasch, M., Org-1, the Drosophila ortholog of Tbx1, is a direct activator of known identity genes during muscle specification. Development 139:5 (2012), 1001–1012.
71. Schnetz, M.P., Bartels, C.F., Shastri, K., Balasubramanian, D., Zentner, G.E., Balaji, R., et al. Genomic distribution of CHD7 on chromatin tracks H3K4 methylation patterns. Genome Research 19 (2009), 590–601.
72. Sinha, S., Abraham, S., Gronostajski, R.M., Campbell, C.E., Differential DNA binding and transcription modulation by three T-box proteins, T, TBX1 and TBX2. Gene 258 (2000), 15–29.
73. Sinha, T., Li, D., Théveniau-Ruissy, M., Hutson, M.R., Kelly, R.G., Wang, J., Loss of Wnt5a disrupts second heart field cell deployment and may contribute to OFT malformations in DiGeorge syndrome. Human Molecular Genetics 24 (2015), 1704–1716.
74. Sobin, C., Kiley-Brabeck, K., Karayiorgou, M., Lower prepulse inhibition in children with the 22q11 deletion syndrome. The American Journal of Psychiatry 162 (2005), 1090–1099.
75. Stoller, J.Z., Huang, L., Tan, C.C., Huang, F., Zhou, D.D., Yang, J., et al. Ash2l interacts with Tbx1 and is required during early embryogenesis. Experimental Biology and Medicine 235 (2010), 569–576.
76. Swerdlow, N.R., Weber, M., Qu, Y., Light, G.A., Braff, D.L., Realistic expectations of prepulse inhibition in translational models for schizophrenia research. Psychopharmacology 199 (2008), 331–388.
77. Tammela, T., Zarkada, G., Nurmi, H., Jakobsson, L., Heinolainen, K., Tvorogov, D., et al. VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling. Nature Cell Biology 13 (2011), 1202–1213.
78. Vincent, S.D., Buckingham, M.E., How to make a heart: The origin and regulation of cardiac progenitor cells. Current Topics in Developmental Biology 90 (2010), 1–41.
79. Vitelli, F., Morishima, M., Taddei, I., Lindsay, E.A., Baldini, A., Tbx1 mutation causes multiple cardiovascular defects and disrupts neural crest and cranial nerve migratory pathways. Human Molecular Genetics 11 (2002), 915–922.
80. Vitelli, F., Taddei, I., Morishima, M., Meyers, E.N., Lindsay, E.A., Baldini, A., A genetic link between Tbx1 and fibroblast growth factor signaling. Development 129 (2002), 4605–4611.
81. Wang, W., Razy-Krajka, F., Siu, E., Ketcham, A., Christiaen, L., NK4 antagonizes Tbx1/10 to promote cardiac versus pharyngeal muscle fate in the ascidian second heart field. PLoS Biology, 11, 2013, e1001725.
82. Watanabe, Y., Zaffran, S., Kuroiwa, A., Higuchi, H., Ogura, T., Harvey, R.P., et al. Fibroblast growth factor 10 gene regulation in the second heart field by Tbx1, Nkx2-5, and Islet1 reveals a genetic switch for down-regulation in the myocardium. Proceedings of the National Academy of Sciences of the United States of America 109 (2012), 18273–18280.
83. Xu, H., Cerrato, F., Baldini, A., Timed mutation and cell-fate mapping reveal reiterated roles of Tbx1 during embryogenesis, and a crucial function during segmentation of the pharyngeal system via regulation of endoderm expansion. Development 132 (2005), 4387–4395.
84. Xu, H., Chen, L., Baldini, A., In vivo genetic ablation of the periotic mesoderm affects cell proliferation survival and differentiation in the cochlea. Developmental Biology 310 (2007), 329–340.
85. Xu, H., Morishima, M., Wylie, J.N., Schwartz, R.J., Bruneau, B.G., Lindsay, E.A., et al. Tbx1 has a dual role in the morphogenesis of the cardiac outflow tract. Development 131 (2004), 3217–3227.
86. Yamagishi, H., Maeda, J., Hu, T., McAnally, J., Conway, S.J., Kume, T., et al. Tbx1 is regulated by tissue-specific forkhead proteins through a common Sonic hedgehog-responsive enhancer. Genes & Development 17 (2003), 269–281.
87. Zhang, Z., Baldini, A., In vivo response to high-resolution variation of Tbx1 mRNA dosage. Human Molecular Genetics 17:1 (2008), 150–157.
88. Zhang, Z., Baldini, A., Manipulation of endogenous regulatory elements and transgenic analyses of the Tbx1 gene. Mammalian Genome 21 (2010), 556–564.
89. Zhang, Z., Cerrato, F., Xu, H., Vitelli, F., Morishima, M., Vincentz, J., et al. Tbx1 expression in pharyngeal epithelia is necessary for pharyngeal arch artery development. Development 132 (2005), 5307–5315.
90. Zhang, Z., Huynh, T., Baldini, A., Mesodermal expression of Tbx1 is necessary and sufficient for pharyngeal arch and cardiac outflow tract development. Development 133 (2006), 3587–3595.